
Efavirenz 600mg Tablet
Marketer
Globela Pharma Pvt Ltd
Salt Composition
Efavirenz (600mg)
Overview Efavirenz 600mg Tablet
Efavirenz 600mg tablets are antiretroviral medications combating HIV, the virus causing AIDS. This treatment helps manage HIV, strengthening your immune system's response. By controlling HIV infection, Efavirenz lessens the risk of related complications and extends life expectancy. Administered with or without food, it's always part of a combined HIV medication regimen. Consistent, timely medication intake maximizes efficacy and minimizes HIV drug resistance. Continue treatment as directed by your physician. Common, typically mild, side effects include headaches, nausea, vomiting, abdominal discomfort, tiredness, diarrhea, and skin rashes. Report persistent or bothersome symptoms to your doctor immediately. Seek immediate medical attention for severe skin reactions or liver problems. Inform your doctor of any pre-existing liver, kidney, or skin conditions before starting treatment. Regular blood tests monitor blood cell counts and liver function during therapy. Avoid alcohol to minimize liver damage risk. Pregnant or nursing individuals require medical consultation prior to use. If HIV-positive, practice safe sex using barrier methods (condoms) and avoid sharing personal items to prevent transmission.
Uses of Efavirenz 600mg Tablet
Managing HIV
Major Benefits of Efavirenz 600mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 600mg Efavirenz tablet should be taken on an empty stomach.
Common Side effects of Efavirenz 600mg Tablet:
- Headache
- Nausea
- Dizziness
- Vomiting
- Increased liver enzymes
- Insomnia (difficulty in sleeping)
- Sleepiness
- Abnormal dreams
- Anxiety
- Itching
- Difficulty in paying attention
- Rash
- Abdominal pain
- Diarrhea
- Depression
- Fatigue
- Pain
- Decreased appetite
How to use Efavirenz 600mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Efavirenz 600mg Tablet should be administered on an empty stomach.
How Efavirenz 600mg Tablet works:
Efavirenz 600mg tablets inhibit HIV replication within human cells, halting further viral production.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using alcohol concurrently with Efavirenz 600mg tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking a 600mg Efavirenz tablet during pregnancy carries a confirmed risk to the fetus. While generally avoided, a physician might exceptionally prescribe it in life-threatening circumstances where potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on current evidence, the use of 600mg Efavirenz tablets while breastfeeding appears to pose minimal risk to the infant. Studies in humans indicate a low likelihood of significant harm to the nursing child.
DrivingUNSAFE
Taking a 600mg Efavirenz tablet can reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
The use of 600mg Efavirenz tablets in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should exercise caution when using 600mg Efavirenz tablets, potentially requiring dosage modification under medical supervision. Efavirenz 600mg tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Efavirenz 600mg Tablet :
NA
Facts to Know About Efavirenz 600mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Non-nucleoside reverse transcriptase inhibitor |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Non-nucleoside reverse transcriptase inhibitors |
